Image: © kasto – Fotolia.com
Microbiological Testing
The Central Issue With microbiological testing being a vital component in the laboratory element of any clinical trial, the site for such tests – be it local, regional or central – should be given plenty of consideration in order to ensure quality and suitability Microbiological testing is very important in all clinical trials – it is the organisational structure of the laboratory stage in any trial for a new medicinal product, and can involve the following: O
Tests which require quick medical decisions or routine analyses – usually performed in a local lab
24
O
that is a structural or affiliated subdivision of a clinical centre (study site) Tests with a high level of result unification – for example, assessment of drug safety panel, lab diagnostics, or simple pharmacodynamic studies – or, in cases where the required tests
Andrey Karelin, Maxim Belotserkovsky, Veronika Khokhlova and Olga Sazonova at PSI CRO
O
cannot be performed in local labs, specialised central labs are used Tests which are not routinely performed, but are required by the study protocol – for example, pharmacokinetic studies, brand new methods of molecular diagnostics or complex pharmacodynamic studies – and use special labs June 2014